Skip to content

Clinical trials

Completed Phase 3 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 3 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20032
20051
20062
20072
20082
20101
20131
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
Alliance for Clinical Trials in Oncology2
European Organisation for Research and Treatment of Cancer - EORTC2
Fred Hutchinson Cancer Center2
BeiGene1
Case Comprehensive Cancer Center1
French Study Group on Chronic Lymphoid Leukemia1
INSYS Therapeutics Inc1
Jonsson Comprehensive Cancer Center1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia21
Hodgkin Disease16
Leukemia, Lymphocytic, Chronic, B-Cell16
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Mantle-Cell16
Lymphoma, B-Cell, Marginal Zone15
Lymphoma, Non-Hodgkin15
Multiple Myeloma15
Lymphoma, Follicular14
Lymphoma, Large-Cell, Immunoblastic14

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.